NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone…
Heritage Distilling Co. Announces Listing on NASDAQ and Pricing of Initial Public Offering
GIG HARBOR, Wash., Nov. 22, 2024 (GLOBE NEWSWIRE) — Heritage Distilling Holding Company Inc. (“Heritage” or the “Company”) (Nasdaq: CASK), a leading craft distiller of…
Gelteq Limited Closes US$5.2 Million Initial Public Offering
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) — Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and…